Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)

NCT00306891 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Cediranib
DRUG: Cediranib 30 - 90 mg

Sponsor

AstraZeneca